Search for: "Watson v. Watson"
Results 1041 - 1060
of 1,500
Sorted by Relevance
|
Sort by Date
13 Jan 2010, 3:00 am
(IP Factor) Netherlands: Court of Appeal, The Hague: Costs of procedure : Lundbeck v Tiefenbacher, Centrafarm Services and Ratiopharm (EPLAW) Poland: First judgment on differences between sponsorship and advertising of pharmaceutical product (Class 46) US: USPTO to begin recalculating patent term following Wyeth v Kappos (Patently-O) (Patent Docs) US: CAFC confirms PTO is miscalculating (undercalculating) delays in prosecution and the corresponding patent term adjustment: Wyeth… [read post]
15 Sep 2010, 2:40 am
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic Vancocin;… [read post]
4 Feb 2009, 6:30 am
Watson, 243 Va. 128, 141 (1992). [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
11 Sep 2019, 4:00 am
Morgan v Bevin (2018). [read post]
4 Jan 2015, 9:03 am
A legal challenge to S.1 of DRIPA by MPs David Davis and Tom Watson is under way. [read post]
4 Apr 2025, 6:30 am
Heller and McDonald v. [read post]
10 Jul 2009, 8:32 am
” See Watson v. [read post]
13 Oct 2010, 5:00 am
Aug. 16, 2010) (citing to Restatement (Third) of Torts: Products Liability § 2b (1998) in support of adoption of risk-utility test); Watson v. [read post]
8 Jun 2011, 11:43 am
Watson, but I'll be watching closely to see what happens in the battle of Lawyer v. [read post]
4 May 2011, 4:13 am
(Docket Report) Provigil (Modafinil) – EU announces anti-trust probe into a Cephalon – Teva deal concerning generic Provigil (The IP Factor) (GenericsWeb) Valsartan – Norway: District Court of Oslo forbids Actavis to market any products containing Valsartan produced by using the process QSSA Route C until 13 May 2011 (EPLAW) Welchol (Colesevelam) – US: Daiichi Sankyo, Genzyme file patent infringement complaint against Watson in response to Para IV certification… [read post]
19 Mar 2020, 1:33 pm
³Watson Laboratories, Inc. v. [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
2 Aug 2007, 9:14 am
Another criminal case being argued in October is Watson v. [read post]
9 Apr 2025, 12:01 pm
Merger v. [read post]
22 Jun 2020, 7:10 am
Inst. v. [read post]
15 May 2013, 4:00 am
Watson Crick – one of the discoverers of DNA, opposes gene patenting: “Life’s instructions ought not be controlled by legal monopolies created at the whim of Congress or the courts”[v]. [read post]
6 May 2015, 5:03 am
Watson, 423 U.S. 411, 416, 96 S. [read post]
21 Jan 2014, 9:01 am
In Fein v. [read post]
10 Nov 2017, 9:21 am
Dietz & Watson, Inc., 679 F.3d 1372 (Fed. [read post]
